The incidence of major birth defects following in vitro fertilization by Zádori, János et al.
P1: ZBU
Journal of Assisted Reproduction and Genetics pp762-jarg-458497 February 27, 2003 11:29 Style file version June 3rd, 2002
Journal of Assisted Reproduction and Genetics, Vol. 20, No. 3, March 2003 ( C° 2003)
SHORT COMMUNICATION
SZEGED, HUNGARY
The Incidence of Major Birth Defects
Following In Vitro Fertilization
Submitted September 24, 2002; accepted September 26, 2002
Purpose : To evaluate the risk of congenital mal-
formations in newborns delivered after IVF-ET in
comparison with matched controls from spontaneous
pregnancies.
Methods : A total of 12,920 deliveries were subjected to
retrospective analysis. A total of 301 neonates were eval-
uated. The incidence of major birth defects was com-
pared with controls matched with regard to age, gravidity,
parity, and previous obstetric outcome after spontaneous
pregnancies.
Results : The incidence of major congenital abnormalities
was not significantly higher (p > 0:05) among the cases
(1.90%) than among the controls (1.15%).
Conclusions : The risk of major birth defects following IVF-
ET is comparable with that of spontaneously conceived,
matched pregnancies.
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INTRODUCTION
The rate of birth defects following in vitro fertilization
embryo transfer (IVF-ET) varies from 3.4 to 9.0%
(1–4) in the literature. The comparison of ICSI and
IVF children taking part in an identical follow-up
study did not show any increased risk of major
malformations in the ICSI group (4). Control
selection (national or clinical control) from a
different population (3) creates the problem of
differences in screening methods, management of
pregnancy, and perinatal care between cases and
controls (1,2). In both cases, only stratification
procedures reveal the influence of assisted repro-
ductive technology (ART) on the incidence of birth
defects (1,2).
METHODS
We performed a retrospective study from
January 1, 1995 to December 31, 2001. The IVF-ET
group comprised 188 neonates from singleton, 74
from twin, and 39 from triplet pregnancies. We
collected controls matched regarding maternal age,
previous parity, and gravidity. Triplets were analyzed
in the crude distribution (data not given in the
table). Congenital malformations were diagnosed
by the same experienced neonatologist, on the
basis of physical examination, chest, abdominal
or skull X-ray, and ultrasonography (cardiac, ab-
dominal, head, etc.) according to International
Code of Diagnosis (ICD) criteria. Birth defects
were classified as major congenital malformations
(e.g. congenital heart defects, gastrointestinal mal-
formations, genitourinary tract malformations,
bone malformations, etc.) or as minor anomalies
(e.g. hypertelorism, low-set ears, etc.). Babies
with major congenital or structural malforma-
tions were admitted to the Neonatal Intensive
Care Unit (NICU) for further observation and
treatment.
Comparison modification was unnecessary as we
used a matched control group. Consequently, the ef-
fect of IVF-ET on the birth per se can be evalu-
ated. Statistical analysis was performed with the SPSS
program (5).
RESULTS
The incidence of major congenital abnormali-
ties (ICD-9) was not significantly higher (p > 0:05)
among the cases (n D 5, 1.90%) than among the con-
trols (n D 3, 1.15%) (Table I). The 39 triplets ex-
hibited no major malformations. The prevalence was
lower than reported by others (1,3), and significantly
lower than that in Western Australia (9.0%) (3).
Birth defects were diagnosed 4 weeks after delivery,
in contrast with the 1-year follow-up by Hansen (3).
The longer follow-up could not explain the difference:
the prevalence of all types of congenital abnormalities
in Hungary is 4% at delivery and 8% by 25 years of
age (6). When the analysis included pregnancies ter-
minated because of fetal abnormalities detected pre-
natally (C2 cases during the 6-year period vs. C1:0%
in the Hungarian national database control) (6), the
statistical relation (2.67% vs. 2.25%, p > 0:05) was
unchanged. The rate of major birth defects was com-
parable with the clinical average (1.90% vs. 2.20%,
p > 0:05).
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Table I. Distribution of Major Congenital Defects
IVF-ET group (n D 262) Matched control group (n D 262)
Type of congenital Singleton Twin Total Singleton Twin Total
anomalies (n D 188) (n D 74) (n D 262) (n D 188) (n D 74) (n D 262)
Cardiovascular 1 1 2 1 1
Chromosomal 1 1
Gastrointestinal 1 1 1 1
Other 1 1 1 1
Total 4 1 5a 1 2 3b
a1.9% of the total number of IVF-ET neonates.
b1.1% of the total number of matched control group neonates.
CONCLUSION
The matching procedure for establishment of a con-
trol group will clearly most closely reflect the rela-
tive risk of the ART method. Differences in absolute
risk of congenital abnormalities can be influenced by
maternal age, certain maternal diseases, medications,
toxic habits, enviromental toxic effects and popula-
tion variation. The different prenatal screening meth-
ods applied (e.g., nuchal translucency, chorion biopsy)
and national guiding principles concerning prenatally
detected malformations can also significantly modify
the perinatal outcome concerning congenital anoma-
lies. Therefore, it is very important to collect safety
data prospectively as assisted reproductive technol-
ogy has been showing a dramatic increase worldwide
in infertility therapy.
Use of matched controls to evaluate the perinatal
effects of IVF-ET on the incidence of major birth de-
fects demonstrate that the risk because of the method
itself is minimal.
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